ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.
Mucosal Immunol
; 15(4): 745-761, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35418673
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Orthomyxoviridae Infections
/
Influenza, Human
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Mucosal Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Suecia